Randomized trial assesses overall survival with symptom monitoring in cancer treatment, suggesting potential benefits of electronic reporting.
This study assesses overall survival associated with electronic patient-reported symptom monitoring vs usual care during routine cancer treatment.
No takes yet. Share an insight, caveat, or question.
Basch et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: